Latest News and Press Releases

PALO ALTO, Calif., July 8, 2015 (GLOBE NEWSWIRE) -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address significant unmet needs in reproductive medicine, announced...

PALO ALTO, Calif., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that...

PALO ALTO, Calif., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, today announced...

Results show NT100 was well-tolerated, no serious adverse events Data suggest NT100 may support maternal-fetal tolerance, has potential to complement existing therapies to maximize pregnancy,...

RESPONSE is Studying NT100 in Pregnant Women With Unexplained Recurrent Pregnancy Loss PALO ALTO, Calif., June 26, 2014 (GLOBE NEWSWIRE) -- Nora Therapeutics, a biotechnology company focused...

PALO ALTO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that...